In the same way, the immunoreactivity of LAMP-1, cathepsin D (CatD), and HSP73 has proven to be significantly lower in the neurons of substantia nigra in patients with PD compared to healthy controls. This evidence concerns the gene LAMP1 and Parkinson disease.